Loading...

Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis

BACKGROUND: Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti‐vascular endothelial growth factor (anti‐VEGF) modalities can reduce oedema and thereby improve vision and prevent further visual loss. These drugs have replaced laser photoco...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cochrane Database Syst Rev
Main Authors: Virgili, Gianni, Parravano, Mariacristina, Evans, Jennifer R, Gordon, Iris, Lucenteforte, Ersilia
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Ltd 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481463/
https://ncbi.nlm.nih.gov/pubmed/28639415
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007419.pub5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!